| Literature DB >> 26026993 |
Herman Autrup1, Frank A Barile2, Bas J Blaauboer3, Gisela H Degen4, Wolfgang Dekant5, Daniel Dietrich6, Jose L Domingo7, Gio Batta Gori8, Helmuth Greim9, Jan G Hengstler4, Sam Kacew10, Hans Marquardt11, Olavi Pelkonen12, Kai Savolainen13, Nico P Vermeulen14.
Abstract
The present debate on chemicals with Hormonal activity, often termed 'endocrine disruptors', is highly controversial and includes challenges of the present paradigms used in toxicology and in hazard identification and risk characterization. In our opinion, chemicals with hormonal activity can be subjected to the well-evaluated health risk characterization approach used for many years including adverse outcome pathways. Many of the points arguing for a specific approach for risk characterization of chemicals with hormonal activity are based on highly speculative conclusions. These conclusions are not well supported when evaluating the available information.Keywords: endocrine disruptors; endocrine toxicology; regulatory/policy; risk assessment
Mesh:
Substances:
Year: 2015 PMID: 26026993 DOI: 10.1093/toxsci/kfv082
Source DB: PubMed Journal: Toxicol Sci ISSN: 1096-0929 Impact factor: 4.849